FindTrial
Sign In

A clinical trial to study the level of inflammatory mediators like cytokinines and metalloproteinases in cerebro spinal fluid of patients with subacute sclerosing panencephalitis.

Cerebrospinal Fluid Proinflammatory Cytokines and Matrix Metalloproteinases in Patients with Subacute Sclerosing Panencephalitis.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/006082
Enrollment
30
Registered
2011-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: lumbar puncture to obtain csf sample 1 ml. of patients of subacute sclerosing panencephalitis: 1 ml of csf Control Intervention1: csf of control patients 1 ml .patients who are undergoi

Sponsors

DEPARTEMENT OF NEUROLOGY,CHATRAPATI SAHUJI MAHARAJ MEDICAL UNIVERSITY, LUCKNOW UP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all patients of subacute sclerosing panencephalitis who fullfill the jabbour criterion

Exclusion criteria

Exclusion criteria: patients of tubercular meningitis,AIDS,fungal meningitis, viral meningitis ,viral encephalitis and other infectious meningitis

Design outcomes

Primary

MeasureTime frame
LEVELS OF PROINFLAMMATORY MARKERS IN CSF OF PATIENTS WITH SUBACUTE SCLEROSING PANENCEPHALITISTimepoint: CORELATION WILL BE MADE BETWEEN CSF PROINFLAMMATORY MARKERS LEVEL AND CLINICAL,STAGING,EEG AND RADIOLOGICAL FEATURES;STUDY ON SUBACUTE SCLEROSING PANENCEPHALITISTimepoint: CSF PROINFLAMMATORY LEVELS IN PATIENTS OF SUBACUTE SCLEROSING PANENCEPHALITIS—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactPROFF. R K GARG
garg50@yahoo.com05222258852

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026